Proglumetacin

Proglumetacin used in musculoskeletal and joint disorders.


Adult Dose
Dose: 150 to 300 mg
Single Dose: 220 (225)
Frequency: 12 hourly
Route: PO
Instructions:
Neonatal
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Paedriatic
Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group
Characteristics
. It is of Synthetic origin and belongs to Indoleacetic Acid. It belongs to Cyclo-oxygenase inhibitor pharmacological group on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents pharmacological group.The Molecular Weight of Proglumetacin is 1076.60.
Contraindications
Proglumetacin is contraindicated in conditions like Neonates,Renal impairment,Hepatic impairment.
Effects
The symptomatic adverse reactions produced by Proglumetacin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Gastrointestinal disturbances.
Indications
Proglumetacin is primarily indicated in conditions like Acute gout attack, Bursitis, Dysmenorrhoea, Osteoarthritis, Pain, Rheumatic diseases, Rheumatoid arthritis, Spondylosis, Tendinitis.
Interactions
No data regarding the interactions of Proglumetacin was found.
Interfrence
Risks
Drug should not be given to patients suffering from Kidney dysfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Storage
Warnings
Not recommended for children under 16 years, pregnancy, lactation. Use carefully in renal, hepatic or cardiac impairment and in asthma, elderly, GI lesions, bleeding disorders.
Back to List

Any information that appears on this website page is provided for the purpose of general information. This website has been compiled in good faith by HMIS.Online. However, no guarantee is made as to the completeness, validity or accuracy of the information it contains.